Katamesh, A.A.; Abdel-Bar, H.M.; Break, M.K.B.; Hassoun, S.M.; Subaiea, G.M.; Radwan, A.; Abo El-Enin, H.A.
Tailored Intranasal Albumin Caged Selegiline-α Synuclein siRNA Liposome with Improved Efficiency in Parkinson’s Model. Pharmaceutics 2025, 17, 243.
https://doi.org/10.3390/pharmaceutics17020243
AMA Style
Katamesh AA, Abdel-Bar HM, Break MKB, Hassoun SM, Subaiea GM, Radwan A, Abo El-Enin HA.
Tailored Intranasal Albumin Caged Selegiline-α Synuclein siRNA Liposome with Improved Efficiency in Parkinson’s Model. Pharmaceutics. 2025; 17(2):243.
https://doi.org/10.3390/pharmaceutics17020243
Chicago/Turabian Style
Katamesh, Ahmed A., Hend Mohamed Abdel-Bar, Mohammed Khaled Bin Break, Shimaa M. Hassoun, Gehad Mohammed Subaiea, Amr Radwan, and Hadel A. Abo El-Enin.
2025. "Tailored Intranasal Albumin Caged Selegiline-α Synuclein siRNA Liposome with Improved Efficiency in Parkinson’s Model" Pharmaceutics 17, no. 2: 243.
https://doi.org/10.3390/pharmaceutics17020243
APA Style
Katamesh, A. A., Abdel-Bar, H. M., Break, M. K. B., Hassoun, S. M., Subaiea, G. M., Radwan, A., & Abo El-Enin, H. A.
(2025). Tailored Intranasal Albumin Caged Selegiline-α Synuclein siRNA Liposome with Improved Efficiency in Parkinson’s Model. Pharmaceutics, 17(2), 243.
https://doi.org/10.3390/pharmaceutics17020243
